Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Arcturus Therapeutics Holdings Inc. (ARCT) had Return on Equity of -5.99% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$17.15M |
|
$-13.45M |
|
-- |
|
$17.15M |
|
$33.66M |
|
$-16.51M |
|
$3.06M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-16.51M |
|
$-15.75M |
|
27.19M |
|
27.19M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$249.20M |
|
$7.42M |
|
$33.14M |
|
$282.34M |
|
$31.70M |
|
-- |
|
$26.09M |
|
$57.78M |
|
$224.56M |
|
$224.56M |
|
$224.56M |
|
27.23M |
|
| Cash Flow Statement Financials | |
$-58.04M |
|
$-0.32M |
|
$1.69M |
|
$293.91M |
|
$237.25M |
|
$-56.67M |
|
$18.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-96.27% |
|
-96.27% |
|
-- |
|
-78.41% |
|
-78.41% |
|
$-58.36M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
2.16 |
|
41.72 |
|
|
Return on Equity |
-5.99% |
-5.99% |
|
-4.76% |
|
-5.99% |
|
$8.25 |
|
$-2.15 |
|
$-2.13 |
|